Phenanthridine

Phenanthridine

SCHEMBL8604527

N=S(=O)=O.c1ccc2c(c1)cnc1ccccc12

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 2/20 0.77
KDM4E B2RXH2 2/20 0.77
CYP3A4 P08684 1/20 0.46
TOP2A P11388 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A2 P05177 2/20 0.41
MAPT P10636 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
RECQL P46063 1/20 0.40
ERN1 O75460 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PDE10A Q9Y233 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenanthridine SCHEMBL30823553 0.88 GPR3 (1.00) GPR3KDM4ECYP3A4TOP2AMEN1
Phenanthridine SCHEMBL9106884 0.88 GPR3 (1.00) GPR3KDM4ECYP3A4TOP2AMEN1
Phenanthridine SCHEMBL30914262 0.88 GPR3 (1.00) GPR3KDM4ECYP3A4TOP2AMEN1
Phenanthridine SCHEMBL8666 0.88 GPR3 (1.00) GPR3KDM4ECYP3A4TOP2AMEN1
Phenanthridine SCHEMBL23003530 0.86 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2AMEN1
Phenanthridine SCHEMBL460289 0.86 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2AMEN1
Phenanthridine SCHEMBL3702845 0.86 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2AMEN1
Phenanthridine SCHEMBL2422346 0.86 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2AMEN1
Phenanthridine SCHEMBL8505090 0.86 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2AMEN1
Phenanthridine SCHEMBL2421052 0.86 GPR3 (0.95) GPR3KDM4ECYP3A4TOP2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5783699-A MAY BE CONJUGATED TO ANTIGENS, HAPTENS, ANTIBODIES IN IMMUNOASSAYS ABBOTT LABORATORIES (US) 1998-07-21 US disclosed
US-5669819-A IMMUNOASSAY ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5565570-A REACTING AMINE WITH SULFONYL HALIDE IN INERT SOLVENT IN PRESENCE OF BASE TO FORM METAL SALT OF SULFONAMIDE, ACYLATING WITH ACTIVATED PHENANTHRIDINE-6-CARBOXYLIC ACID TO FORM CHEMILUMINESCENT SALT ABBOTT LABORATORIES (US) 1996-10-15 US disclosed
US-5545739-A E.G., 5-METHYL-6-(N-2-CARBOXYETHYL-N=(2-CARBOXYETHYL)-PHENANTHRIDIN IUMCARBOXAMIDE CHLORIDE; IMMUNOASSAYS; STABILITY; SENSITIVITY ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5543524-A FORMING A SULFONAMIDE FROM AND AMINE AND A SULFONYL HALIDE AND AND ACYLATING WITH A CARBONYL HALIDE OF AN ACTIVATED ACRIDINE SALT ABBOTT LABORATORIES (US) 1996-08-06 US disclosed
US-5468646-A Chemiluminescent acridinium salts ABBOTT LABORATORIES (US) 1995-11-21 US disclosed
EP-0273115-A2 Chemiluminescent acridinium and phenanthridinium salts ABBOTT LABORATORIES (US) 1988-07-06 EP disclosed